WHC is still in active development. Read this to understand our approach.
depiction of MDBNTXARNGRHEV-UHFFFAOYSA-N.svg
isomerdesign

Capeserod

Verificar en isomerdesign

drugmap

SL65.0155

Verificar en drugmap

Data

InChI: InChI=1S/C23H25ClN4O4/c24-18-14-17(20-21(19(18)25)31-13-12-30-20)22-26-28(23(29)32-22)16-7-10-27(11-8-16)9-6-15-4-2-1-3-5-15/h1-5,14,16H,6-13,25H2

Sinónimos: DB-030409, FT-0735661, 2009AC, GTPL29, AJ-23687, UNII-8163770L8P, CHEMBL2027925, AKOS016011606, PDSP1_001263, Capeserod [INN],SL650155, SCHEMBL4707724,SL65.0155, KB-243722, 769901-96-4,Capeserod,capeserod, SL65.0155, ZINC603773, 5-(8-AMINO-7-CHLORO-2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)-3-[1-(2-PHENYLETHYL)PIPERIDIN-4-YL]-1,3,4-OXADIAZOL-2(3H)-ONE, BDBM86038, 8163770L8P, SL650155, 5-(8-Amino-7-chloro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-3-(1-phenethylpiperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one, PDSP2_001247

Estimated data

Solubilidad: -5.224 (log(S) in mol/L prediction using SolTranNet)

Addictivity Prediction: 34.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.